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Thomas Francis in front of the Special Projects Research Building 
where the Poliomyelitis Vaccine Evaluation Center was housed.
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“The 1954 Poliomyelitis Vaccine Field Trial Areas.” In Evaluation of the 1954 eld trial of poliomyelitis vaccine: Final report.
The story of the eradication of polio in the United Stats is well known. 
However, the role played by the University of Michigan School of Public Health 
(UMSPH) is not as familiar. This poster highlights the achievements of the 
UMSPH in carrying out one of the most successful vaccination campaigns in 
history, which eventually led to the conquest of polio.
Polio quarantine sign 
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Signs of the Times
“In the early 1950s, before polio vaccines were available, polio outbreaks 
caused more that 15,000 cases of paralysis each year in the United States.”1 
The United State’s polio epidemic of 1952 involved almost 60,000 cases from 
all forty-eight states, and the territories of Alaska, Hawaii, and Puerto Rico. 
Thousands of children were paralyzed, many were conned to crutches or 
wheelchairs for life, and others, whose breathing muscles were paralyzed, 
were placed inside a sealed ventilator chamber known as an iron lung. 
The Iron Lung and Other Equipment. Whatever Happened to Polio? 
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The 1954 Field Trial
In 1954, the U.S.Vaccine Advisory Committee approved a eld test of Dr. Jonas 
Salk’s polio vaccine. The trials, which were among the largest and most 
publicised clinical trials ever undertaken, were sponsored by the National 
Foundation for Infantile Paralysis (March of Dimes).
 Under the direction of Dr.Thomas Francis, 
Salk’s mentor during a fellowship at UMSPH, 
the  massive controlled eld trial was 
launched. Almost two million children in the 
United States, between ages of six and nine, 
participated.
The 1955 Polio Vaccine Trial 
Announcement
On April 12, 1955, in the University of 
Michigan’s Rackham Auditorium, Dr. 
Thomas Francis Jr. director of the 
Poliomyelitis Vaccine Evaluation Center at 
the University of Michigan School of Public 
Health, announced to the world that the 
Salk polio vaccine was up to 90% eective 
in preventing paralytic polio.  
For parents, the Salk vaccine was 
a godsend, with active polio 
cases plummeting by almost 90 
percent in the rst two years 
following its introduction. Polio 
has now been virtually 
eradicated in countries using 
Salk's vaccine. The Salk polio 
vaccine transformed a disease 
that once horried America into 
a memory. 
Thomas Francis and Jonas Salk at April 12, 1955 Press Conference
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